Check out the study “Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment”

Check out the study “Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment”
Share

Have you already read this interesting publication on Scientific Reports? 📑 📢

Check out the study “Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment” to delve into the key findings and implications.

We congratulate the team for their hard work and dedication! Read the publication here: https://www.nature.com/articles/s41598-022-22470-z